Record Fee-Related Earnings
KKR reported fee-related earnings of $0.98 per share, total operating earnings of $1.33 per share, and adjusted net income of $1.18 per share, marking some of the highest figures in the company's history.
Strong Management Fee Growth
Management fees reached $996 million, up 18% year-over-year, driven by Americas XIV and broader fundraising initiatives.
Robust Investment Performance
The private equity portfolio was up 5% for the quarter and 13% year-over-year. Infrastructure appreciated 14% over the last 12 months.
Significant Deployment and Monetization
KKR deployed $37 billion year-to-date, with $18 billion in Credit. Realized performance and investment income totaled $2.6 billion over the last 12 months, up over 20% year-over-year.
Strong Fundraising and Growth in ABF
Raised $28 billion in Q2, with asset-based finance commitments more than tripling to $6.5 billion. ABF AUM increased over 20% to $75 billion year-over-year.
Expansion in Asia
KKR's Asia operations have grown significantly, managing over $75 billion in assets and engaging in various transactions across the region.
Strategic Acquisition in Life Sciences
Acquired a majority stake in HealthCare Royalty Partners, adding $3 billion in AUM and expanding KKR's life sciences footprint.